Close
  Indian J Med Microbiol
 

Table 2: Description of healthcare-associated infections experienced by patients in the sample to determine the difference in secondary bacterial and fungal infections following the use of tocilizumab among COVID-19 patients

Table 2: Description of healthcare-associated infections experienced by patients in the sample to determine the difference in secondary bacterial and fungal infections following the use of tocilizumab among COVID-19 patients